Sertraline in the treatment of anxiety disorders

Depression and Anxiety

Volumn 11, Issue 4, 2000, Pages 139-157

  Hirschfeld, Robert M A ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Anxiety disorders; Depression; Obsessive compulsive disorder; Panic disorder; Pharmacotherapy; PTSD; Sertraline; Social phobia; SSRIs

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CLOMIPRAMINE; FLUOXETINE; FLUVOXAMINE; MONOAMINE OXIDASE INHIBITOR; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ANXIETY NEUROSIS; CLINICAL TRIAL; DRUG EFFICACY; FATIGUE; GASTROINTESTINAL SYMPTOM; HUMAN; NERVOUSNESS; OBSESSION; PANIC; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SOCIAL PHOBIA; XEROSTOMIA;

ADULT; CLINICAL TRIALS; CLOMIPRAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMAN; MALE; OBSESSIVE-COMPULSIVE DISORDER; PANIC DISORDER; PHOBIC DISORDERS; QUALITY OF LIFE; REMISSION INDUCTION; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; STRESS DISORDERS, POST-TRAUMATIC; TIME FACTORS; TREATMENT OUTCOME;

EID: 0033851819     PISSN: 10914269     EISSN: None     Source Type: Journal    
DOI: 10.1002/1520-6394(2000)11:4<139::AID-DA1>3.0.CO;2-C     Document Type: Review

References (74)

1. Sertraline treatment of children and adolescents with obsessive-compulsive disorder or depression: Pharmacokinetics, tolerability, and efficacy
2. Double-blind flexible dose multicenter study of sertraline and placebo in outpatients with post-traumatic stress disorder
3. A double-blind, randomized, placebo-controlled, multi-center study of brofaromine in the treatment of post-traumatic stress disorder
4. Reversible monoamine oxidase-A inhibitors in panic disorder
5. Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder
6. A double-blind comparison of sertraline and clomipramine in outpatients with obsessive-compulsive disorder
7. Sertraline treatment of comorbid post-traumatic stress disorder and alcohol dependence
8. Results of a double-blind placebo controlled trial of a new serotonin uptake inhibitor, sertraline, in the treatment of obsessive-compulsive disorder
9. Clomipramine in the treatment of patients with obsessive-compulsive disorder
10. Exposure therapy, fluvoxamine, or combination treatment in obsessive-compulsive disorder: One-year follow-up
11. Sertraline in social phobia
12. Biological therapies for posttraumatic stress disorder: An overview
13. Pharmacotherapy of social anxiety disorder
14. Treatment of posttraumatic stress disorder with amitriptyline and placebo
15. Response characteristics to antidepressants and placebo in post-traumatic stress disorder
16. Treatment of social phobia with clonazepam and placebo
17. Double-blind comparison of sertraline and placebo in patients with post-traumatic stress disorder
18. Antidepressant treatment of posttraumatic stress disorder and major depression in veterans
19. Fluvoxamine or clomipramine in the treatment of obsessive-compulsive disorder: A multicenter, randomised, double-blind, parallel group comparison
20. Cognitive-behavioral and pharmacological treatments of social phobia. A controlled study
21. Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder: Comparison of fluvoxamine and desipramine
22. Efficacy of fluvoxamine in obsessive-compulsive disorder: A double-blind comparison with placebo
23. Treatment of social phobia with atenolol
24. Sertraline as a treatment for panic disorder
25. New developments in behaviour therapy for obsessive-compulsive disorder
26. Double-blind parallel comparison of three dosages of sertraline and placebo in outpatients with obsessive-compulsive disorder
27. A 1-year double-blind placebo-controlled fixed dose study of sertraline in the treatment of obsessive-compulsive disorder
28. Clomipramine, clonazepam, and clonidine treatment of obsessive-compulsive disorder
29. Panic anxiety and its treatment
30. Effect of fluvoxamine on panic disorder
31. Placebo-controlled trial of fluoxetine and phenelzine for obsessive-compulsive disorder
32. Pharmacotherapy of post-traumatic stress disorder with a novel psychotropic
33. Sertraline for social phobia: A double blind, placebo-controlled crossover study
34. Sertraline efficacy in depressed combat veterans with post-traumatic stress disorder
35. Behavioral versus pharmacological treatments of obsessive compulsive disorder: A meta-analysis
36. Pharmacotherapy for post-traumatic stress disorder using phenelzine or imipramine
37. Placebo-controlled, multicenter study of sertraline treatment for obsessive-compulsive disorder
38. A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder: Collaborative Paroxetine Panic Study Investigators
39. Long-term evaluation of paroxetine, clomipramine and placebo in panic disorder
40. Treatment of obsessive-compulsive disorder with domipramine and desipramine in children and adolescents: A double-blind crossover comparison
41. Phenelzine vs atenolol in social phobia: A placebo-controlled comparison
42. Sertraline in the treatment of panic disorder: A multisite, double-blind, placebo-controlled fixed dose investigation
43. Sertraline in children and adolescents with obsessive-compulsive disorder: A multicenter randomized controlled trial
44. Open trial of fluvoxamine treatment for combat-related posttraumatic stress disorder
45. An open trial of paroxetine in patients with noncombat-related, chronic posttraumatic stress disorder
46. Sertraline in the treatment of patients with social phobia
47. Outcome assessment and clinical improvement in panic disorder: Evidence from a randomized controlled trial of fluoxetine and placebo
48. Efficacy, safety, and gradual discontinuation of clonazepam in panic disorder: A placebo-controlled, multicenter study using optimized dosages
49. Sertraline in social phobia
50. Controlled comparison of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder
51. Sertraline treatment of panic disorder: Combined results from two placebo-controlled trials
52. Sertraline in the treatment of panic disorder: A double-blind multicenter trial
53. Social anxiety disorder: Designing a pharmacologic treatment strategy
54. The pharmacotherapy of social phobia
55. Sertraline in the treatment of panic disorder: A flexible-dose multicenter trial
56. Multi-dimensional outcome and quality of life in panic disorder: The effects of sertraline treatment
57. Methodologies and outcomes from the sertraline multicenter flexible-dose trials
58. Fluvoxamine in the treatment of OCD: A multicenter double-blind, placebo-controlled study in outpatients
59. A 2-year study of sertraline in the treatment of obsessive-compulsive disorder
60. Sertraline in the treatment of rape victims with post-traumatic stress disorder
61. Maintenance drug treatment of panic disorder. I. Results of a prospective placebo-controlled comparison of alprazolam and imipramine
62. Paroxetine treatment of generalized social phobia (social anxiety disorder): A randomized controlled trial
63. Continuation treatment of OCD: Double-blind and open-label experience with fluoxetine
64. Clomipramine versus phenelzine in obsessive-compulsive disorder: A controlled clinical trial
65. Sertraline treatment of social phobia: A 20-week, double-blind, placebo-controlled study
66. Sertraline in social phobia
67. Fluoxetine in posttraumatic stress disorder
68. The effect of citalopram in panic disorder
69. A fixed-dose comparison of 20, 40, or 60 mg paroxetine or placebo in the treatment of obsessive-compulsive disorder
70. A double-blind, parallel, 12-week comparison of sertraline and placebo in patients with panic disorder [Poster]
71. Quality of life differences in sertraline and placebo responsive panic disorder patients
72. Paroxetine versus clomipramine in the treatment of obsessive-compulsive disorder